OR WAIT null SECS
February 16, 2022
Agreement provides pharma firms with an RWD and commercialization solution
February 15, 2022
Publication finds that only about 40% of retail pharmacists feel equipped to discuss biosimilars with patients
February 10, 2022
A conversation with Michael Abrams, co-founder and managing partner, Numerof & Associates
Examining the divestment risks, as more large companies look to spin off consumer health and other business units to focus on branded pharmaceuticals
February 08, 2022
Software firm merges with PharmaLex Group
Collaboration, the companies note, is expected to further engage patients
February 04, 2022
A sit-down with members of the Deloitte team, who discuss the findings of the company’s yearly research and development report
February 01, 2022
Grows Syner-G’s presence in RTP, a biotech hub that continues to develop
January 31, 2022
CDMO will use its BFS knowledge to support production out of its Kaysersberg, France plant
Acquires Medaxis, a patient engagement company